Normal non-transgenic BALB/c mice as well as wild type and SH2D2A-deficient Id-specific TCR-transgenic mice were injected subcutaneously with a high dose of MOPC315 myeloma cells (2×106 cells). The gene discussed is SH2D2A; the disease is plasma cell myeloma.